Evidence map›Paper›PMID 29225893›Full record

ArticleBMJ open diabetes research & care2017

A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway.

Martin Fried, Karin Dolezalova, Adam P Chambers, Elliott J Fegelman, Robin Scamuffa, Michael L Schwiers, Jason R Waggoner, Martin Haluzik, Randy J Seeley

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02283632 (A Trial of the Jejunal Diversion Procedure), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02283632 nacompletednot on this map

A Trial of the Jejunal Diversion Procedure (Side-to-side Jejuno-jejunostomy) (Europe)

TypeinterventionalSponsorEthicon Endo-SurgeryRan2014 to 2016Enrolled15ConditionsDiabetes, ObesityArmsJejunal Diversion
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Gut-Centric Model of Metabolic Homeostasis.Journal of diabetes science and technology · 2022
    Article
  5. Article
  6. A rodent model of partial intestinal diversion: a novel metabolic operation.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Martin FriedOB Klinika a.s, Prague, Czech Republic.
Karin DolezalovaOB Klinika a.s, Prague, Czech Republic.
Adam P ChambersGLP-1 & Obesity Pharmacology, Novo Nordisk A/S, Malov, Denmark.
Elliott J FegelmanEthicon, Inc, Cincinnati, OH, USA.
Robin ScamuffaEthicon, Inc, Cincinnati, OH, USA.
Michael L SchwiersEthicon, Inc, Cincinnati, OH, USA.
Jason R WaggonerEthicon, Inc, Cincinnati, OH, USA.
Martin HaluzikInstitute for Clinical and Experimental Medicine, Centre for Experimental Medicine, Diabetes Centre, Prague, Czech Republic.
Randy J SeeleyDepartment of Surgery, Internal Medicine and Nutritional Science, University of Michigan, Ann Arbor, MI, USA.
Ocní klinika · CZInstitute of Clinical and Experimental Medicine · CZNovo Nordisk (Denmark) · DKUniversity of Michigan–Ann Arbor · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
NIDDK NIH HHS P30 DK020572
6 · The paper itself

Abstract

objectiveTo explore partial jejunal diversion (PJD) via a side-to-side jejuno-jejunostomy for improved glycemic control in type 2 diabetes mellitus (T2DM). PJD is an anatomy-sparing, technically simple surgery in comparison to the predominate metabolic procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). Positive results in a rodent model prompted a human proof-of-concept study. RESEARCH DESIGN AND

methodsPre-clinically, 71 rats were studied in a model of metabolic dysfunction induced by a high-fat diet; 33 animals undergoing one of two lengths of PJD were compared with 18 undergoing sham, 10 RYGB and 10 jejuno-ileal bypass. Clinically, 15 adult subjects with treated but inadequately controlled T2DM (hemoglobin A1c (HbA1c) of 8.0%-11.0%), body mass index of 27.0-40.0 kg/m

resultsPre-clinically, positive impacts with PJD on glucose homeostasis, cholesterol, and body composition versus sham control were demonstrated. Clinically, PJD was performed successfully without serious complications. Twelve months post-surgery, the mean (SD) reduction from baseline in HbA1c was 2.3% (1.3) (p<0.01).

conclusionsPJD may provide an anatomy sparing, low-risk, intervention for poorly controlled T2DM without significant alteration of the patient's lifestyle. The proof-of-concept study is limited by a small sample size and advanced disease, with 80% of participants on insulin and a mean time since diagnosis of over 10 years. Further study is warranted. TRIAL REGISTRATION NUMBER: NCT02283632; Pre-results.

Indexed as

MetabolicSurgeryType 2 Diabetes

Identifiers

PMID29225893
PMCPMC5706485
OpenAlexW2751904995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.